Skip to main content
BAXTER INTERNATIONAL INC logo

BAXTER INTERNATIONAL INC — Investor Relations & Filings

Ticker · BAX ISIN · US0718131099 LEI · J5OIVXX3P24RJRW5CK77 US Manufacturing
Open in API
Filings indexed 2,456 across all filing types
Latest filing 2016-04-29 Merger & Acquisition
Country US United States of America
Listing US BAX

About BAXTER INTERNATIONAL INC

https://www.baxter.com/

Baxter International Inc. is a global healthcare company focused on saving and sustaining lives. The company provides a broad portfolio of essential products across renal care, hospital, and surgical settings. Key offerings include technologies for acute and chronic dialysis, sterile intravenous (IV) solutions, infusion systems, clinical nutrition, and critical care. Baxter develops, manufactures, and markets a range of medical devices, connected care solutions, and advanced injectable pharmaceuticals. The company's products are used by healthcare professionals in hospitals, clinics, and homes to provide smarter, more personalized care for patients.

Recent filings

Filing Released Lang Actions
425 Filing
Merger & Acquisition Classification · 95% confidence The document references Rule 425 under the Securities Act of 1933, which is commonly used for merger communications and tender offers. It mentions an offer by Baxter International Inc. to exchange shares of Baxalta Incorporated for Baxter shares, indicating a merger or acquisition-related communication. The text is brief and appears to be a filing related to merger communications rather than a full report or announcement. Therefore, the document fits the category of Merger & Acquisition filings (MA).
2016-04-29 English
425 Filing
Merger & Acquisition Classification · 95% confidence The document references Rule 425 under the Securities Act of 1933, which is commonly used for merger communications and tender offers. It mentions an offer by Baxter International Inc. to exchange shares of Baxalta Incorporated for shares of Baxter, indicating a merger or acquisition-related communication. The text is brief and appears to be a filing related to merger communications rather than a full report or announcement. Therefore, the document fits the category of Merger & Acquisition filings.
2016-04-28 English
8-K
Regulatory Filings Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated April 27, 2016, by Baxter International Inc. It reports a temporary suspension of trading under the company's employee benefit plans due to a potential blackout period related to an exchange offer of shares. The content focuses on notifying about trading restrictions for directors and officers, referencing regulatory provisions such as Section 16 of the Securities Exchange Act and the Sarbanes-Oxley Act. There are no financial statements, earnings data, or detailed management discussion. The document is a current report on a specific event rather than a financial report or earnings release. Therefore, it fits the category of a Regulatory Filing (RNS), which is a general regulatory announcement that does not fit other specific categories.
2016-04-27 English
425 Filing
Merger & Acquisition Classification · 95% confidence The document references Rule 425 under the Securities Act of 1933, which is commonly used for merger communications and takeover bid disclosures. It mentions an offer by Baxter International Inc. to exchange shares of Baxalta Incorporated for Baxter shares, indicating a merger or acquisition-related filing. The text is brief and relates to the communication of the offer, consistent with a merger communication filing rather than a full report or announcement. Therefore, the document fits the Merger & Acquisition (MA) category.
2016-04-27 English
425 Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed by Baxter International Inc. It references Rule 425 under the Securities Act of 1933 and discusses a potential special trading blackout related to an exchange offer involving Baxter shares and Baxalta shares. The content focuses on notifying directors and Section 16 officers about trading restrictions during the blackout period. There are no financial statements, earnings data, or detailed financial analysis present. The document is primarily a regulatory announcement about trading restrictions and compliance with federal law, not a financial report or earnings release. It also includes a notice (Exhibit 99.1) which is a form of blackout notice. Given the nature of the document as a regulatory filing informing about trading restrictions and compliance, and the absence of financial data or report content, the appropriate classification is Regulatory Filings (RNS).
2016-04-27 English
PRIMARY DOCUMENT
Director's Dealing
2016-04-26 English

Browse filings by year

33 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.